Cargando…

Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial

Detalles Bibliográficos
Autor principal: Aniwan, Satimai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Gastrointestinal Endoscopy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995997/
https://www.ncbi.nlm.nih.gov/pubmed/35279974
http://dx.doi.org/10.5946/ce.2022.063
_version_ 1784684405772517376
author Aniwan, Satimai
author_facet Aniwan, Satimai
author_sort Aniwan, Satimai
collection PubMed
description
format Online
Article
Text
id pubmed-8995997
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Society of Gastrointestinal Endoscopy
record_format MEDLINE/PubMed
spelling pubmed-89959972022-04-21 Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial Aniwan, Satimai Clin Endosc Commentary Korean Society of Gastrointestinal Endoscopy 2022-03 2022-03-14 /pmc/articles/PMC8995997/ /pubmed/35279974 http://dx.doi.org/10.5946/ce.2022.063 Text en Copyright © 2022 Korean Society of Gastrointestinal Endoscopy https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Aniwan, Satimai
Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
title Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
title_full Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
title_fullStr Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
title_full_unstemmed Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
title_short Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
title_sort fecal calprotectin as a surrogate marker for mucosal healing after initiating the therapeutic anti-tubercular trial
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995997/
https://www.ncbi.nlm.nih.gov/pubmed/35279974
http://dx.doi.org/10.5946/ce.2022.063
work_keys_str_mv AT aniwansatimai fecalcalprotectinasasurrogatemarkerformucosalhealingafterinitiatingthetherapeuticantituberculartrial